• Japanese
  • Korean
  • Chinese
Cover Image

Nucleic Acid Testing

Abstract

This report analyzes the Global market for Nucleic Acid Testing in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 46 companies including many key and niche players such as Abbott Laboratories, Inc., Agilent Life Sciences and Chemical Analysis, Applied Biosystems Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cepheid, Inc., Genomic Health, Inc., Gen-Probe Inc., Genzyme Corp., Genzyme Genetics, Myriad Genetics, Inc., Novartis AG, QIAGEN NV, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., and Third Wave Technologies, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
  • Nucleic Acid Test
  • Polymerase Chain Reaction or PCR Tests
  • Reverse Transcriptase PCR or RT-PCR Tests
  • Branched DNA or Quantiplex bDNA Tests

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Introduction
  • Current and Future Analysis
  • A Glance at the Nucleic Acid Testing Market
  • Point of Care (POC) Nucleic Acid Tests
  • Lateral Flow Platform-An Alternative to POC Nucleic Acid Testing

2. MARKET TRENDS

  • Veterinary Industry Eyes on Nucleic Acid Testing Kits and Immunodiagnostics
  • Home-Brewing Methods Continue to Dominate the NAPI Markets
  • Molecular Diagnostics - A Largely Untapped Market
  • Low-Priced Commercial Products to Mar the Popularity of Conventional Nucleic Acid Isolation Methods
  • Novel Applications and Technologies Widen Customer Base for Nucleic Acid Isolation Processes
  • FDA Licenses Nucleic Acid Tests Usage for Screening Hepatitis C and HIV
  • Usage of NAT for Screening Additional Categories of HIV in Tissues and Donated Blood Approved by FDA

3. PRODUCT OVERVIEW

  • What is a Nucleic Acid Test?
  • Polymerase Chain Reaction or PCR Tests
  • Reverse Transcriptase PCR or RT-PCR Tests
  • Branched DNA or Quantiplex bDNA Tests
  • Applications of NAT
  • NAT for Hepatitis C Virus Infection (HCV)
  • Qualitative Tests
  • Clinical Uses of Qualitative Nucleic Acid Test
  • Quantitative Tests
  • Real-Time PCR Method
  • Use of NAA for Diagnosing Tuberculosis
  • Factors Hindering the Adoptability of NAA Tests for Tuberculosis
  • Use of NAA for Diagnosing STI
  • Use of Nucleic Acid Sequence-Based Amplification for Diagnosing Dengue Viral RNA
  • Segments of NAT Technology
  • Amplified Probe Technology
  • Signal Amplification
  • Probe Amplification
  • Target Amplification
  • Direct Nucleic Acid Probes
  • Types of Techniques
  • In-situ hybridization (ISH)
  • Southern Blot
  • Liquid Hybridization
  • Working Procedure of Nucleic Acid Tests
  • Impediments for Using Technology
  • Capturing Methods for Discovering Nucleic Acid Lateral Flow (NALF)
  • Multiplex Nucleic Acid Testing

4. REGIONAL MARKET PERSPECTIVE

4a. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • A Snapshot of the US Nucleic Acid Testing Market
    • Soaring Demand from Various Applications Drives the US NAPI Market
    • Use of NAT in STDs and HPV
  • B. Market Analytics
    • Table 1: US Recent Past, Current & Future Analysis for Nucleic Acid Testing Markets with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

4b. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Overview of Select Regional Markets
    • Europe
    • A Glance at the Europe' s Nucleic Acid Testing and Blood Safety Market
    • Table 2: European Recent Past, Current & Future Analysis for Nucleic Acid-based Amplification Reagents Markets by Geographic Region-France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
    • Table 3: European 10-Year Perspective for Nucleic Acid-based Amplification Reagents by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain and Rest of Europe Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
    • Table 4: European Recent Past, Current & Future Analysis for Nucleic Acid-based Amplification Reagents by Segment- Genetic Testing, Infectious Diseases and Transplant Diagnostics Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
    • Table 5: European 10-Year Perspective for Nucleic Acid-based Amplification Reagents by Segment - Percentage Breakdown of Revenues for Genetic Testing, Infectious Diseases and Transplant Diagnostics Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
    • China
    • Chinese Nucleic Acid Testing Market: An Overview
  • B. Market Analytics
    • Table 6: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Testing Markets with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

5. PRODUCT LAUNCHES

  • DaAn Gene Unveils Nucleic Acid Testing Kit for Influenza A H1N1 Virus
  • Sequenom Launches SensiGene Cystic Fibrosis Carrier Screening Test
  • Jeevan Introduces Nucleic Acid Testing

6. STRATEGIC CORPORATE DEVELOPMENTS

  • Gen-Probe Acquires Prodesse
  • STRATEC Takes Over Invitek
  • Becton, Dickinson and Company Takes Over Handy Lab
  • Gen-Probe Acquires Tepnel Life Sciences
  • Micronics and Biosearch Technologies Ink Licensing Agreement
  • Quidel and BioHelix Sign Agreement
  • BlueGnome Signs Agreement with Rubicon Genomics
  • DaAn Gene to Setup Four Joint Ventures
  • Gen-Probe and Chiron to Extend Partnership
  • EnviroLogix Inks Licensing Agreement with Ionian Technologies
  • HandyLab Extends Partnership with Epoch Biosciences
  • QIAGEN to Provide Molecular Testing Solutions to Bio-Manguinhos
  • Nanogen Signs Licensing and Supply Agreement with HandyLab
  • Blood System Laboratories and Florida Blood Services Establish a Joint Venture
  • Teva Collaborates with Compugen
  • QIAGEN Takes-Over Biotage' s Biosystems Unit
  • QIAGEN Snaps Up Corbett Life Science
  • Agilent Technologies to Expand API Manufacturing Plant
  • Polyclone Bioservices to Establish Nucleic Acid Testing Units in India
  • Pacgen Biopharmaceuticals Signs LoI with Medigen Biotechnology
  • easyDNA Establishes New DNA Testing Center in India
  • Apollo Chennai Establishes Nucleic Acid Testing Unit

7. OTHER DEVELOPMENTS

  • Nanosphere Receives FDA Approval for Respiratory Virus Assay
  • Roche Diagnostics Obtains FDA Approval for Broader Usage of Nucleic Acid Test
  • US and European Patent Authorities Award Patents to Gen-Probe for NAT
  • The National Institute of Allergy and Infectious Diseases Awards $770,000 to Micronics
  • DaAn Gene Obtains SFDA Approval for Marketing Nucleic Acid Test Kits
  • Luminex Molecular Diagnostics xTAG Respiratory Viral Panel Approved by FDA
  • Siemens Healthcare' s Apple iMac OSX Operating System Approved by FDA
  • Micronics Receives NIH Grant for Developing HIV POC Test

8. FOCUS ON SELECT PLAYERS

  • Abbott Laboratories, Inc. (US)
  • Agilent Life Sciences and Chemical Analysis (US)
  • Applied Biosystems Group (US)
  • Becton, Dickinson and Company (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Cepheid, Inc. (US)
  • Genomic Health, Inc. (US)
  • Gen-Probe Inc. (US)
  • Genzyme Corp. (US)
  • Genzyme Genetics (US)
  • Myriad Genetics, Inc. (US)
  • Novartis AG (Switzerland)
  • QIAGEN NV (Netherlands)
  • Roche Diagnostics (US)
  • Siemens Healthcare Diagnostics, Inc. (US)
  • Third Wave Technologies, Inc. (US)

9. GLOBAL MARKET PERSPECTIVE

  • Table 7: World Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
  • Table 8: World 10-Year Perspective for Nucleic Acid Testing by Geographic Region -Percentage Breakdown of Revenues for US and Rest of World Markets for 2006, 2009 & 2015

III. COMPETITIVE LANDSCAPE

Show More
RELATED REPORTS
* 2014-2018 Japanese Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
  • Published:
  • Nov 12, 2014
  • USD 5500
  • 860 Pages

* 2014-2018 US Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
  • Published:
  • Nov 12, 2014
  • USD 6200
  • 880 Pages

* 2014-2018 World Nucleic Acid Testing/NAT Market: Emerging Technologies and Strategic Profiles of Leading Suppliers
  • Published:
  • Nov 12, 2014
  • USD 3500
  • 180 Pages

* 2014-2018 World Nucleic Acid Testing/NAT Market: Facilities, Test Volumes, and Sales Forecasts by Country
  • Published:
  • Nov 12, 2014
  • USD 2450
  • 15 Pages

* 2014-2018 World Nucleic Acid Testing/NAT Market: Latest Instrumentation and Strategic Profiles of Leading Suppliers
  • Published:
  • Nov 12, 2014
  • USD 3500
  • 103 Pages

* 2014-2018 World Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers
  • Published:
  • Nov 12, 2014
  • USD 2100
  • 134 Pages

* 2014-2018 World Nucleic Acid Testing/NAT Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
  • Published:
  • Nov 12, 2014
  • USD 3500
  • 109 Pages

* 2014-2018 World Nucleic Acid Testing/NAT Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants
  • Published:
  • Nov 12, 2014
  • USD 2500
  • 120 Pages

* 2014-2018 World Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
  • Published:
  • Nov 12, 2014
  • USD 20900
  • 1050 Pages

* Cancer Diagnostics: New Developments, Market Growth and Opportunities in the use of Circulating Tumour Cells and Circulating Nucleic Acids
  • Published:
  • Sep 08, 2014
  • USD 3016
  • 170 Pages

Browse more Biotechnology Equipment Market Research Reports

Pricing